These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5939888)

  • 1. Changes in ward behaviour of severely disabled schizophrenic patients.
    Ekdawi MY
    Br J Psychiatry; 1966 Mar; 112(484):265-7. PubMed ID: 5939888
    [No Abstract]   [Full Text] [Related]  

  • 2. Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines.
    Schooler NR; Boothe H; Goldberg SC
    Arch Gen Psychiatry; 1971 Aug; 25(2):138-47. PubMed ID: 5106102
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of Tybamate in chronic schizophrenia. (Minor tranquilizers as adjunct therapy in psychosis).
    Serafetinides EA; Clark ML
    Dis Nerv Syst; 1971 Aug; 32(8):567-71. PubMed ID: 5094163
    [No Abstract]   [Full Text] [Related]  

  • 4. Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time.
    Goldberg SC; Schooler NR; Mattsson N
    J Nerv Ment Dis; 1967 Aug; 145(2):158-62. PubMed ID: 4861752
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuropsychological observations with psychosis and somatic treatment. Neuropsychological examinations of psychiatric patients.
    Small IF; Small JG; Milstein V; Moore JE
    J Nerv Ment Dis; 1972 Jul; 155(1):6-13. PubMed ID: 5035734
    [No Abstract]   [Full Text] [Related]  

  • 6. [Attempt to influence social relations by intentional regime interventions in chronic and terminal states of schizophrenia].
    Soucek Z; Zvĕrina J; Curdová E
    Cesk Psychiatr; 1967 Oct; 63(5):335-41. PubMed ID: 4383642
    [No Abstract]   [Full Text] [Related]  

  • 7. Increase in gustatory acuity and hyperarousal in schizophrenia.
    Fischer R; Ristine LP; Wisecup P
    Biol Psychiatry; 1969 Jul; 1(3):209-18. PubMed ID: 4390893
    [No Abstract]   [Full Text] [Related]  

  • 8. Maintenance treatment of chronic schizophrenia with neuroleptic drugs.
    Morgan R; Cheadle J
    Acta Psychiatr Scand; 1974; 50(1):78-85. PubMed ID: 4207901
    [No Abstract]   [Full Text] [Related]  

  • 9. CHANGES IN SCHIZOPHRENIC PSYCHOPATHOLOGY AND WARD BEHAVIOUR AS A FUNCTION OF PHENOTHIAZINE TREATMENT.
    GOLDBERG SC; KLERMAN GL; COLE JO
    Br J Psychiatry; 1965 Feb; 111():120-33. PubMed ID: 14270524
    [No Abstract]   [Full Text] [Related]  

  • 10. A preliminary study of SKF-14,336 in chronic schizophrenia.
    Simpson GM; Iqbal J; Iqbal F
    Curr Ther Res Clin Exp; 1966 Sep; 8(9):447-51. PubMed ID: 4957931
    [No Abstract]   [Full Text] [Related]  

  • 11. Three-day hospitalization--a model for intensive intervention.
    Weisman G; Feirstein A; Thomas C
    Arch Gen Psychiatry; 1969 Nov; 21(5):620-9. PubMed ID: 5823484
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of family-orientated therapy with hospitalized schizophrenics.
    Esterson A; Cooper DG; Laing RD
    Br Med J; 1965 Dec; 2(5476):1462-5. PubMed ID: 5849436
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of TPN-12 in 25 chronic schizophrenic patients].
    Medina Gil C; Samaniego Rodríguez C
    Arch Neurobiol (Madr); 1969; 32(4):559-73. PubMed ID: 5380328
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship between results on some psychological tests and outcome in schizophrenia.
    Reed JL
    Acta Psychiatr Scand; 1971; 47(3):223-9. PubMed ID: 5142564
    [No Abstract]   [Full Text] [Related]  

  • 15. The hospital treatment of the schizophrenic patient. Research design and training programs.
    Michels R
    Int J Psychiatry; 1969 Oct; 8(4):740-3. PubMed ID: 5351383
    [No Abstract]   [Full Text] [Related]  

  • 16. The hospital treatment of the schizophrenic patient.
    May PR
    Int J Psychiatry; 1969 Oct; 8(4):699-722. PubMed ID: 5351378
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of psychiatric inpatients with mesoridazine.
    Krout BM; Stone CB
    Psychosomatics; 1969; 10(4):244-8. PubMed ID: 5808616
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of butaperazine in chronic schizophrenia.
    Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR
    Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043
    [No Abstract]   [Full Text] [Related]  

  • 19. Locus of control and community adjustment among schizophrenic patients.
    Steinberg T; Yu J; Brenner H; Krieger P
    J Clin Psychol; 1974 Jan; 30(1):101. PubMed ID: 4811910
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychotherapy and pharmacotherapy in chronic schizophrenia.
    Grinspoon L; Ewalt JR; Shader R
    Am J Psychiatry; 1968 Jun; 124(12):1645-52. PubMed ID: 5650757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.